investing in innovation

Welcome to Archangels

Archangels is a prominent business angel syndicate, which has been at the forefront of early stage investing in Scotland for more than two decades. Our members invest in and mentor promising start-up and early stage companies from Scotland’s vibrant technology and life sciences sectors.

Archangels’ Portal:

Archangels Impact Evaluation of activities:
(Click here to view)


Looking for investment?

Archangels welcomes funding submissions from start-ups and early stage companies in the technology and life sciences sectors. The syndicate invests equity only but will assist with the raising of debt as part of a package where appropriate.

All companies applying for funding will be initially assessed using the criteria listed below. Please note that the list is not exhaustive and criteria may be waived in special circumstances.

  • The company must be based in Scotland.
  • The company must have high growth potential with international sales potential.
  • The company should have defendable technology, whether through IP or know-how
  • The company should be in a sector which qualifies under the Enterprise Investment Scheme.
  • The funding proposal may cover a range from ‘proof of concept’ through expansion capital and can include start-up, early stage or MBOs.
  • The preferred level of investment is £250-500k but can cover a range from £50k to £2m.

Assuming that the basic investment criteria are met, companies should submit a business plan to Archangels for review. This document should include an overview of the company together with a brief financial summary outlining how much funding is being sought and how it will be used.

Want to apply?

Send your business plan to:

"Over a period of 17 years I have worked with Archangel in 3 of their companies. Throughout that time, without exception, they have been tremendously supportive and motivational investors. Knowledgeable and close to the business without interfering in its development, calmly appreciative of good news and, most importantly, unfazed by knowledge of the regular setbacks which are the inevitable counterpart of overall progress at these highly entrepreneurial ventures."

Ian Stevens CEO, Touch Bionics